Medical Science News

RSS

NYU Oral Cancer Center receives $3.1 million grant to explore the interplay between nerves and cancer

NYU Oral Cancer Center has been awarded a five-year, $3.1 million grant (R01 CA231396) by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

1 Mar 2021

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.

1 Mar 2021

A backbone free energy study of SARS-CoV-2 variants of concern

A recent study by scientist Robert Penner at the Institut des Hautes Études Scientifiques in France utilizes free energy calculations to predict effective antiviral targets that are highly conserved, surface-accessible for interaction, and resistant to mutation.

1 Mar 2021

Is transposable element expression affected by SARS-CoV-2 infection?

A study by researchers in Israel aims to establish whether TE expression is altered in SARS-CoV-2 infected cells, and explores the implications for host immune response.

1 Mar 2021

Protein kinase inhibitors could help treat immunodeficiency in HIV patients

HIV infections are treated with antiviral drugs which effectively prevent the disease from developing. While pharmacological HIV therapy has advanced considerably, the virus cannot be entirely eliminated from the body with currently available drugs.

1 Mar 2021

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

Scientists compared the in vitro efficacy and cytotoxicity profiles of PF-00835231 and remdesivir in two human model systems for SARS-CoV-2 infection.

1 Mar 2021

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test

A team of international scientists has recently evaluated a surrogate virus neutralization test for severe acute respiratory coronavirus 2 (SARS-CoV-2) and observed that it is highly efficacious for detecting anti-SARS-CoV-2 neutralizing antibodies in serum samples. According to the scientists, the test can be effectively used for population-level serosurveillance and evaluation of vaccine efficacy. The study is currently available on the medRxiv* preprint server.

1 Mar 2021

Study: Gut microbiome can predict changes in Type 2 diabetes related glucose regulation

A study carried out by researchers from the Institute of Genomics, University of Tartu revealed that human gut microbiome can be used to predict changes in Type 2 diabetes related glucose regulation up to four years ahead.

1 Mar 2021

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

A scientific team led by Brian Brown, PhD, Professor of Genetics and Genomic Sciences and Associate Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai (New York, New York), has been awarded $500,000 from Alliance for Cancer Gene Therapy to advance a promising immunotherapy approach to fight lung cancer and other solid tumor cancers.

1 Mar 2021

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech’ vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.

1 Mar 2021

Early tracheostomy could reduce recovery time in critical COVID-19, say researchers

A new study by researchers at the Northwestern University Feinberg School of Medicine, USA, reports the findings of a study on the safety of tracheostomy of critically ill patients and the feasibility of decannulation in most survivors. The researchers view this as a means to improve care in these patients

1 Mar 2021

New paper discusses how smoking may affect risk for COVID-19

A new paper published online in the Annals of the American Thoracic Society discusses how smoking may affect risk for COVID-19 and the types of research that are needed to better understand the link between smoking and COVID-19 risk.

1 Mar 2021

One in seven people in England show SARS-CoV-2 antibodies, finds study

The REal-time Assessment of Community Transmission-2 (REACT-2) program completed its fifth round of community surveys in the days between January 26 and February 8, 2021. The findings appear in a new article in the BMJ on February 25, 2021, showing that natural infection and vaccination together account for around 14% seropositivity rates in England at present.

1 Mar 2021

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

A new study by scientists in the UK raises the very useful hypothesis that natural infection may help spread the vaccine thinner without loss of efficacy.

1 Mar 2021

Researchers to conduct large meta-analysis of fetomaternal complications in COVID-19

A new preprint on the medRxiv* server describes the protocol written for a study that aims to perform a systematic analysis of all the data available on the effect of this syndrome on pregnancy.

1 Mar 2021

Researchers assess SARS-CoV-2 surface contamination risks in hospital setting

Researchers analyzed the surface swabs for SARS-CoV-2 RNA and the infectivity in a hospital setting by both qRT-PCR and a viral culture assay. They also determined the suitability for sequence analysis and phylogenetically identifying the source of the virus.

1 Mar 2021

Free-ranging minks exhibit high titers of SARS-CoV-2 antibodies in Utah

Researchers at the U.S. Centers for Disease Control and Prevention (CDC) report outbreaks of coronavirus disease (COVID-19) on mink farms in Utah, United States. They surveyed around farms for evidence of exposure and found high SARS-CoV-2 titers, suggesting a possible viral transmission pathway to native wildlife.

28 Feb 2021

Efficacy of polymeric nano-micelles depends on expression level of c-Myc

The Innovation Center of NanoMedicine (Director General: Prof. Kazunori Kataoka, Location: Kawasaki in Japan, Abbreviation: iCONM) reported in ACS Nano (Impact Factor: 14.588 in 2019) together with the group of Prof. Yu Matsumoto of Otorhinolaryngology and Head and Neck Surgery (Prof. Tatsuya Yamasoba) and the group of Prof. Horacio Cabral of the Department of Bioengineering (Prof. Ryo Miyake) in the University of Tokyo that the efficacy of polymeric nano-micelles with different drug activation profile depends on the expression level of c-Myc, one of the major proto-oncogene, has been developed.

27 Feb 2021

Newly identified genes increase risk of obesity and also protect against this disease

People living with obesity tend to have unhealthy glucose and lipid levels in their blood, as well as high blood pressure.

27 Feb 2021

Study on artificial microswimmers could improve the efficacy of targeted cancer therapy

A Mason Engineering researcher has discovered that artificial microswimmers accumulate where their speed is minimized, an idea that could have implications for improving the efficacy of targeted cancer therapy.

27 Feb 2021

Medical Science News

NYU Oral Cancer Center receives $3.1 million grant to explore the interplay between nerves and cancer

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A backbone free energy study of SARS-CoV-2 variants of concern

Is transposable element expression affected by SARS-CoV-2 infection?

Protein kinase inhibitors could help treat immunodeficiency in HIV patients

Comparative analysis of SARS-CoV-2 antivirals leads to new potential treatment for COVID-19

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test

Study: Gut microbiome can predict changes in Type 2 diabetes related glucose regulation

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

Single-dose of BNT162b2 vaccine may not be protective without prior SARS-CoV-2 infection

Early tracheostomy could reduce recovery time in critical COVID-19, say researchers

New paper discusses how smoking may affect risk for COVID-19

One in seven people in England show SARS-CoV-2 antibodies, finds study

Could SARS-CoV-2 antibody tests before first vaccine dose help increase coverage and protection?

Researchers to conduct large meta-analysis of fetomaternal complications in COVID-19

Researchers assess SARS-CoV-2 surface contamination risks in hospital setting

Free-ranging minks exhibit high titers of SARS-CoV-2 antibodies in Utah

Efficacy of polymeric nano-micelles depends on expression level of c-Myc

Newly identified genes increase risk of obesity and also protect against this disease

Study on artificial microswimmers could improve the efficacy of targeted cancer therapy

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News